Federal Testosterone Lawsuits Move Forward, as Court Prepares to Hold October Conference, Bernstein Liebhard LLP Reports

Share Article

The Firm is evaluating potential testosterone treatment lawsuits on behalf of men who allegedly experienced heart attacks, strokes, deep vein thrombosis, pulmonary embolism and other life-threatening cardiovascular problems due to their use of prescription low testosterone treatments.

Free Case Review
Our Firm has heard from numerous men who allegedly suffered heart attacks, strokes, deep vein thrombosis, pulmonary embolism and other life-threatening cardiovascular problems due to low testosterone therapies.

Testosterone lawsuits (http://www.testosteronelawsuitcenter.com/) continue to move forward in a multidistrict litigation currently underway in U.S. District Court, Northern District of Illinois, Bernstein Liebhard LLP reports. According to the Court’s calendar, the litigation will convene its next monthly Case Management Conference on October 24, 2014. The conference is slated to begin at 9:00 a.m. (In re: Testosterone Replacement Therapy Product Liability Litigation - MDL No. 2545)

“Our Firm has heard from numerous men who allegedly suffered heart attacks, strokes, deep vein thrombosis, pulmonary embolism and other life-threatening cardiovascular problems due to low testosterone therapies. We are following developments in the federal testosterone litigation very closely, and look forward to the conference later this month” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is now evaluating legal claims on behalf of men who allegedly suffered heart attacks, strokes, deep vein thrombosis, pulmonary embolism and other life-threatening heart problems due to their use of prescription testosterone medications.

Testosterone Treatment Litigation
According to court documents, at more than 200 testosterone treatment lawsuits are now pending in the federal litigation underway in Illinois. All of the claims were filed on behalf of men who allegedly suffered life-threatening cardiovascular events due to their use of drugs like AndroGel, Axiron and Testim. Among other things, plaintiffs claim that the makers of the drugs engaged in marketing that positioned testosterone treatments as an effective remedy for low libido, fatigue and other age-related symptoms, even though the medications are only approved to treat men who suffer from hypogonadism (low testosterone) due to an underlying medical condition. Testosterone plaintiffs further allege that this marketing induced many men to seek treatment with the potentially dangerous drugs, even though they had no real medical need.

Court records indicate that the litigation surrounding low testosterone treatments has been growing since January 2014, when the U.S. Food & Drug Administration (FDA) announced it was investigating the cardiovascular risks associated with the drugs. In September, a panel of FDA advisors recommended that the drugs’ labels be revised to make clear they have not been shown to lessen low libido, fatigue, muscle loss and other age-related symptoms. They also recommended that the manufacturers of testosterone replacement therapies be required to conduct studies of their cardiovascular side effects.*

Men who suffered heart attacks, strokes, or other cardiovascular problems allegedly related to a testosterone treatment may be entitled to compensation for medical bills, lost wages, pain and suffering and more. To learn more about filing a testosterone lawsuit, please visit Bernstein Liebhard LLP’s website, or call 800-511-5092 for a free case review.

*reuters.com/article/2014/09/17/us-usa-health-testosterone-idUSKBN0HC2C320140917, Reuters, September 18, 2014

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.testosteronelawsuitcenter.com/
https://plus.google.com/115936073311125306742?rel=author

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Follow us on
Visit website